The promise of gene editing has been trapped by slow, costly, and fragmented R&D.
We're building AI-native research infrastructure that makes scalable breakthroughs possible.
Mandrake submitted an 11.8 kDa miniprotein binder generated by our ORBIT framework (Oracle-Reseeded Binder design with Interface Targeting). It achieved the competition's only "Strong" classification — beating 321 other designs from labs around the world.
Deep dives from the lab notebook — protein engineering, enzyme design, and scaling gene editing.
Open problems we're tackling. Subscribe to The Assay to hear when the next one drops.
We're not building one gene editor. We're building the infrastructure to create thousands, making gene editing as scalable as software.
Join us to make life programmable. See open roles.
View Careers